Wednesday, July 8, 2026

pharma · Friedreich Ataxia · LRMR

Larimar Therapeutics

Larimar Therapeutics clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Bala Cynwyd, USA HQ
2016 Founded
82 Employees
Public company Type
LRMR · NYSE Ticker
Company details
Status
Public
HQ
Bala Cynwyd, USA
Founded
2016
Employees
82
Programs
3
Drugs
2
Patents
5
Intelligence · Clinical Programs

Larimar Therapeutics projects

1 ClinicalTrials.gov programs sponsored by Larimar Therapeutics.

Larimar Therapeutics has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Nomlabofusp

    Larimar Therapeutics

    Friedreich Ataxia

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

How many clinical projects does Larimar Therapeutics have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.